life science investing Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
life science investing Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
life science investing Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants